Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06401824
Title Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Maastricht University Medical Center
Age Groups: senior | adult
Covered Countries NLD

No variant requirements are available.